EP3630751
CRYSTALLINE FORMS OF 5-BROMO-2,6-DI(1 H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE AND NEW SALTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.5.2018EP published:
27.3.2024EP application number:
18734945.1
EPO information:
European Patent Register
Max expiry date:
29.5.2038
Title in English:
CRYSTALLINE FORMS OF 5-BROMO-2,6-DI(1 H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE AND NEW SALTSLanguage of the patent:
English
Timeline
Today
30.5.2018EP application
27.3.2024EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Name:
Palobiofarma, S.L.Address:
Avenida Ernst Luch 32 TCM3-0401, 08302 Mataro (Barcelona), ES
Inventor
Name:
CUI, KaiAddress:
Changshu Jiangsu 215537, CN
Name:
KONG, WeiyongAddress:
Changshu Jiangsu 215527, CN
Name:
CASTRO-PALOMINO LARIA, Julio CesarAddress:
08302 Mataro (Barcelona), ES
Priority
Number:
PCT/CN2017/086624Date:
31.5.2017Country:
WO
Classification
Categories:
C07D 403/14, A61P 35/00, A61K 31/506